Cargando…
Bronchiolitis obliterans syndrome after lung or haematopoietic stem cell transplantation: current management and future directions
Bronchiolitis obliterans syndrome (BOS) may develop after either lung or haematopoietic stem cell transplantation (HSCT), with similarities in histopathological features and clinical manifestations. However, there are differences in the contributory factors and clinical trajectories between the two...
Autores principales: | Glanville, Allan R., Benden, Christian, Bergeron, Anne, Cheng, Guang-Shing, Gottlieb, Jens, Lease, Erika D., Perch, Michael, Todd, Jamie L., Williams, Kirsten M., Verleden, Geert M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309343/ https://www.ncbi.nlm.nih.gov/pubmed/35898810 http://dx.doi.org/10.1183/23120541.00185-2022 |
Ejemplares similares
-
Beyond Bronchiolitis Obliterans: In-Depth Histopathologic Characterization of Bronchiolitis Obliterans Syndrome after Lung Transplantation
por: Vanstapel, Arno, et al.
Publicado: (2021) -
Bronchiolitis Obliterans Syndrome and Chronic Lung Allograft Dysfunction: Evolving Concepts and Nomenclature
por: Meyer, Keith C., et al.
Publicado: (2013) -
Bronchiolitis obliterans
por: King, Talmadge E.
Publicado: (1989) -
Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial
por: Ruttens, David, et al.
Publicado: (2018) -
Clinical analysis of adenovirus postinfectious bronchiolitis obliterans and nonadenovirus postinfectious bronchiolitis obliterans in children
por: Huang, Fei, et al.
Publicado: (2021)